SITE012-0164

SITE012 (BRA) › SITE012-0164

SITE012-0164

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE012 (BRA) · Dr. Kowalski
consented 2026-03-17

enrolled

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2023-03-13 (study day 171); relationship: RELATED

mild assessed

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-11-25 (study day 63); relationship: not assessed

mild assessed

Grade 3 Colitis — outcome: RECOVERED/RESOLVED; onset 2022-10-17 (study day 24); relationship: not assessed

severe assessed

Data queries

0

No data queries. Open queries would appear here for this patient.